R. Gentry Wilkerson, MD, and Bryan D. Hayes, PharmD, published a letter in this month's issue of Clinical Toxicology. They were reacting to a case description in the October issue of the same journal, in which a patient’s uvular edema was linked to MDMA and treated with icatibant. Drs. Wilkerson and Hayes advised caution about the assumption that the drug induced the angioedema and about the use of such an expensive medication when a causative link is questionable.
Blog Archives
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012